- Home
- MYGN vs BKE Comparison
MYGN vs BKE Comparison
Compare MYGN & BKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- BKE
- Stock Information
- Founded
- MYGN 1991
- BKE 1948
- Country
- MYGN United States
- BKE United States
- Employees
- MYGN N/A
- BKE N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BKE Clothing/Shoe/Accessory Stores
- Sector
- MYGN Health Care
- BKE Consumer Discretionary
- Exchange
- MYGN Nasdaq
- BKE Nasdaq
- Market Cap
- MYGN 744.7M
- BKE 2.2B
- IPO Year
- MYGN 1995
- BKE 1992
- Fundamental
- Price
- MYGN $5.52
- BKE $47.16
- Analyst Decision
- MYGN Hold
- BKE Hold
- Analyst Count
- MYGN 15
- BKE 1
- Target Price
- MYGN $15.14
- BKE $41.00
- AVG Volume (30 Days)
- MYGN 1.8M
- BKE 473.4K
- Earning Date
- MYGN 08-05-2025
- BKE 08-22-2025
- Dividend Yield
- MYGN N/A
- BKE 8.27%
- EPS Growth
- MYGN N/A
- BKE N/A
- EPS
- MYGN N/A
- BKE 3.90
- Revenue
- MYGN $831,300,000.00
- BKE $1,227,330,000.00
- Revenue This Year
- MYGN N/A
- BKE $2.24
- Revenue Next Year
- MYGN $6.68
- BKE $2.17
- P/E Ratio
- MYGN N/A
- BKE $12.10
- Revenue Growth
- MYGN 7.38
- BKE N/A
- 52 Week Low
- MYGN $3.81
- BKE $33.12
- 52 Week High
- MYGN $29.30
- BKE $54.25
- Technical
- Relative Strength Index (RSI)
- MYGN 55.99
- BKE 73.42
- Support Level
- MYGN $4.90
- BKE $43.70
- Resistance Level
- MYGN $5.50
- BKE $45.78
- Average True Range (ATR)
- MYGN 0.25
- BKE 1.01
- MACD
- MYGN 0.09
- BKE 0.04
- Stochastic Oscillator
- MYGN 84.46
- BKE 92.00
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to better-priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.